Evidence map›Paper›PMID 42765041›Full record

Observational studyDrug design, development and therapy2026

Intraoperative Mild Hypothermia Alleviate Acute Postoperative Pain Through Attenuating Sufentanil Metabolism: A Prospective Cohort Study with Experimental Validation.

Yiqi Feng, Yanxia Zhang, Xu Tang, Li Zeng, Qian Fang, Jia Tang, He Huang, Guangyou Duan

Abstract readObservational Study
In one paragraph

Observational study in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yiqi Feng *Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Yanxia Zhang *Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Xu TangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Li ZengDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Qian FangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Jia TangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
He HuangDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.ORCID 0000-0002-1180-3111
Guangyou DuanDepartment of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.ORCID 0000-0002-6199-7882

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inadvertent perioperative hypothermia is common during anesthesia, but its association with acute postoperative pain remains unclear. We investigated whether the cumulative intraoperative temperature exposure below 36°C was associated with postoperative pain after laparoscopic surgery and explored a potential mechanism involving sufentanil disposition and hepatic CYP3A activity. Methods: This single-center prospective observational cohort, included 229 adults undergoing elective laparoscopic abdominal surgery under general anesthesia with continuous tympanic temperature monitoring. The primary clinical endpoint was moderate-to-severe postoperative pain, defined as any numerical rating scale (NRS) score ≥4 within 24 h after surgery. Temperature exposure was summarized as the percentage of the recorded intraoperative period spent below 36°C (percentage of hypothermia time, POH), with POH ≥30% evaluated as the main exposure threshold. Complementary experiments used a mouse plantar-incision model to assess mechanical withdrawal thresholds, plasma sufentanil pharmacokinetics, and hepatic CYP3A catalytic activity under controlled lower-temperature and normothermic conditions. Results: In the clinical cohort, 76 of 229 patients (33.2%) developed NRS ≥4 pain within 24 h. POH ≥30% was independently associated with lower odds of moderate-to-severe postoperative pain (adjusted odds ratio, 0.23; 95% confidence interval, 0.08-0.65; P=0.005), lower early postoperative NRS scores, and less rescue analgesics use. Temperatures <35°C was uncommon, and perioperative complications did not differ between groups. In mice, lower body temperature (32.26±0.48°C) prolonged sufentanil analgesia compared with normothermia (37.32±0.32°C), increased early plasma sufentanil exposure, prolonged elimination half-life, reduced clearance, and decreased hepatic CYP3A catalytic activity. Conclusion: Greater cumulative exposure to mild intraoperative hypothermia was associated with less acute postoperative pain and lower rescue analgesic use after laparoscopic surgery. Experimental findings suggest that lower temperature may prolong sufentanil exposure by suppressing CYP3A-mediated metabolism. These findings do not support inducing hypothermia but indicate that intraoperative temperature may influence opioid pharmacokinetics and should be considered when integrating thermal management with perioperative analgesic strategy.

Indexed as

Analgesics, OpioidHypothermia, InducedPostoperative PainSufentanilAdultAgedAnimalsCohort StudiesCytochrome P-450 CYP3AFemaleHumansMaleMiceMiddle AgedProspective StudiesAnalgesics, OpioidCytochrome P-450 CYP3ASufentanilCYP3Amild hypothermiaopioid pharmacokineticsperioperative temperaturepostoperative painsufentanil

Identifiers

PMID42765041
PMCPMC13589990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.